Downregulation of CD73 surface expression in regulatory as well as effector T cells in chronic HCV infection

2012 ◽  
Vol 50 (01) ◽  
Author(s):  
I Tóth ◽  
AQ Le ◽  
P Hartjen ◽  
A Thomssen ◽  
C Beisel ◽  
...  
2008 ◽  
Vol 46 (01) ◽  
Author(s):  
N Semmo ◽  
M Müller ◽  
C Neumann-Haefelin ◽  
HC Spangenberg ◽  
HE Blum ◽  
...  

Cells ◽  
2019 ◽  
Vol 8 (4) ◽  
pp. 374 ◽  
Author(s):  
Faria Ahmed ◽  
Andrea Ibrahim ◽  
Curtis L. Cooper ◽  
Ashok Kumar ◽  
Angela M. Crawley

Chronic hepatitis C virus (HCV) infection causes generalized CD8+ T cell impairment, not limited to HCV-specific CD8+ T-cells. Liver-infiltrating monocyte-derived macrophages (MDMs) contribute to the local micro-environment and can interact with and influence cells routinely trafficking through the liver, including CD8+ T-cells. MDMs can be polarized into M1 (classically activated) and M2a, M2b, and M2c (alternatively activated) phenotypes that perform pro- and anti-inflammatory functions, respectively. The impact of chronic HCV infection on MDM subset functions is not known. Our results show that M1 cells generated from chronic HCV patients acquire M2 characteristics, such as increased CD86 expression and IL-10 secretion, compared to uninfected controls. In contrast, M2 subsets from HCV-infected individuals acquired M1-like features by secreting more IL-12 and IFN-γ. The severity of liver disease was also associated with altered macrophage subset differentiation. In co-cultures with autologous CD8+ T-cells from controls, M1 macrophages alone significantly increased CD8+ T cell IFN-γ expression in a cytokine-independent and cell-contact-dependent manner. However, M1 macrophages from HCV-infected individuals significantly decreased IFN-γ expression in CD8+ T-cells. Therefore, altered M1 macrophage differentiation in chronic HCV infection may contribute to observed CD8+ T-cell dysfunction. Understanding the immunological perturbations in chronic HCV infection will lead to the identification of therapeutic targets to restore immune function in HCV+ individuals, and aid in the mitigation of associated negative clinical outcomes.


2001 ◽  
Vol 31 (8) ◽  
pp. 2388-2394 ◽  
Author(s):  
Anna M. Grabowska ◽  
Franziska Lechner ◽  
Paul Klenerman ◽  
Paddy J. Tighe ◽  
Stephen Ryder ◽  
...  

2015 ◽  
Vol 62 (2) ◽  
pp. 303-310 ◽  
Author(s):  
Michelle Spaan ◽  
Kim Kreefft ◽  
Gretchen N. de Graav ◽  
Willem P. Brouwer ◽  
Robert J. de Knegt ◽  
...  

2006 ◽  
Vol 36 ◽  
pp. S123
Author(s):  
R.A. Ffrench ◽  
J. Flynn ◽  
K. Goy ◽  
P. Hosseiny ◽  
Y. Pan ◽  
...  

2006 ◽  
Vol 44 (3) ◽  
pp. 475-483 ◽  
Author(s):  
Carla Nisii ◽  
Massimo Tempestilli ◽  
Chiara Agrati ◽  
Fabrizio Poccia ◽  
Guido Tocci ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. e37014 ◽  
Author(s):  
Eleonora Cimini ◽  
Cécile Bonnafous ◽  
Veronica Bordoni ◽  
Eleonora Lalle ◽  
Helene Sicard ◽  
...  

2000 ◽  
Vol 32 ◽  
pp. 33
Author(s):  
C.A. Schirren ◽  
M.C. Jung ◽  
T. Worzfeld ◽  
J.T. Gerlach ◽  
N.H. Gruener ◽  
...  

2021 ◽  
Vol 10 (2) ◽  
pp. 221
Author(s):  
Pil Soo Sung ◽  
Eui-Cheol Shin

Direct-acting antiviral agents (DAAs) that allow for rapid clearance of hepatitis C virus (HCV) may evoke immunological changes. Some cases of rapid de novo hepatocellular carcinoma (HCC) development or early recurrence of HCC after DAA treatment have been reported. During chronic HCV infection, natural killer (NK) cells exhibited a deviant functional phenotype with decreased production of antiviral cytokines and increased cytotoxicity; however, DAA treatment rapidly decreased their cytotoxic function. Effective DAA therapy also suppressed the intrahepatic activation of macrophages/monocytes. This was followed by a decrease in mucosal-associated invariant T (MAIT) cell cytotoxicity without normalization of cytokine production. Rapid changes in the phenotypes of NK and MAIT cells after DAA treatment may attenuate the cytotoxicity of these cells against cancer cells. Moreover, DAA treatment did not normalize the increased frequencies of regulatory T cells even after clearance of HCV infection. Thus, the persistently increased frequency of regulatory T cells may contribute to a local immunosuppressive milieu and hamper the clearance of cancer cells. This review will focus on recent studies describing the changes in innate and adaptive immune responses after DAA treatment in patients with chronic HCV infection in the context of de novo occurrence or recurrence of HCC.


Sign in / Sign up

Export Citation Format

Share Document